|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||1.0000 - 1.0000|
|52 Week Range||0.4000 - 1.0000|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
ROCK HILL, S.C., July 21, 2020 -- Vynleads, Inc. (the “Company” or “Vynleads”) (OTCQB: VYND), a health and wellness technology company dedicated to helping members thrive.
Vynleads, Inc. (the “Company” or “Vynleads”) (VYND), a health and wellness technology company dedicated to helping members thrive naturally and stay out of the emergency room, reports that its “Done with Diabetes” (DWD) Protocol can help people with type-2 diabetes improve their overall health. The DWD Protocol is based on work at London’s Newcastle University by Dr. Roy Taylor, who showed that the remission of type-2 diabetes is linked to a loss of liver fat.